Report: Medtech, biotech and pharma see strong M&A activity | Calif. eye surgery device firm receives $51M funding boost | Stock sale brings in $5.3M for Epigenomics
Web Version
October 17, 2014
ADVAMED SmartBrief
News for medical technology professionals

Top StorySponsored By
Report: Medtech, biotech and pharma see strong M&A activity
A recent report from Mergermarket found that the medtech, biotech and pharma industries had 869 merger and acquisition deals this year totaling $354.3 billion. The report also forecasts that strong M&A activity will likely continue during the fourth quarter and the years ahead, driven in part by forthcoming changes in Medicare reimbursement policies. (10/16)
Share: LinkedInTwitterFacebookGoogle+Email
How Quotas and Data Are Transforming Sales Pay in Medtech
What trends shape how medtech companies pay sales personnel? ZS's 2014 Incentives Practices Research shows more medtech companies are using quotas to determine sales pay, data to help determine those quotas, and automation to administrate plans. Read an executive summary of the report to learn how these trends are transforming sales pay in medtech.
Business & Market Trends
Calif. eye surgery device firm receives $51M funding boost
A round of financing headed by Frontline BioVentures and OrbiMed has pulled in $51 million for MID Labs, which develops devices used during vitrectomy surgeries. The California-based company will use the money to increase its product portfolio and widen its presence in China and the U.S., said CEO Kai Chen. (Boston) (10/16)
Share: LinkedInTwitterFacebookGoogle+Email
Stock sale brings in $5.3M for Epigenomics
Epigenomics, which has developed the Epi proColon test used to diagnose colorectal cancer, has obtained $5.3 million through an offering of shares. Thomas Taapken, Epigenomics' CEO, said the funding will be used to support the company's pursuit for regulatory approval and subsequent sale of the test in China and the U.S. GenomeWeb Daily News (free registration) (10/16)
Share: LinkedInTwitterFacebookGoogle+Email
Industry veteran joins Spine Wave's marketing management team
Laine Mashburn has been tapped to serve as executive vice president of global marketing and business development at Spine Wave. Mashburn previously held executive roles at DePuy Spine and DePuy Synthes, a Johnson & Johnson unit. (10/16)
Share: LinkedInTwitterFacebookGoogle+Email
International Developments
EU approves Thermo Fisher's Ion PGM Dx tool
European regulators have granted Thermo Fisher Scientific the CE-IVD mark to market its Ion PGM Dx System. The technology uses a small DNA sample to analyze genetic variants accurately and with the quick turnaround time required in clinical environments, a company executive said. GenomeWeb Daily News (free registration) (10/16)
Share: LinkedInTwitterFacebookGoogle+Email
Science & Health
Genetic test identifies patients at risk of atrial fibrillation and stroke
Scientists have developed a test that screens for 12 genetic variants to determine risk of ischemic stroke and atrial fibrillation, according to a study in the journal Stroke. Adding the genetic score to risk models for atrial fibrillation could help correctly assess when anticoagulants are needed, particularly among patients younger than 65. Healio (free registration)/Cardiology Today (10/15)
Share: LinkedInTwitterFacebookGoogle+Email
Emerging Technologies
Siemens' advanced cardiovascular ultrasound scanner gets FDA OK
Siemens Healthcare has received FDA clearance for the Acuson SC2000 Prime, the latest version of its ultrasound scanner used for cardiovascular imaging. The company said the system gives doctors a single view of both the heart and dynamic blood flow when performing interventional valve procedures. (free registration) (10/16)
Share: LinkedInTwitterFacebookGoogle+Email
Wireless imaging device from Konica lands FDA clearance
The AeroDR XE wireless digital radiography device, developed by Konica Minolta Medical Imaging, has obtained clearance from the FDA. The device weighs 5.7 pounds and is tailored for use in critical care, intensive care, trauma and emergency suites, although it can also be used in teaching hospitals as well as for bedside imaging and portable applications. (free registration) (10/15)
Share: LinkedInTwitterFacebookGoogle+Email
Featured Press Releases
Government & Regulatory
ITraumaCare's bleeding-control device gets expanded approval from FDA
The FDA has granted iTraumaCare expanded approval for its iTClamp Hemorrhage Control System for use in halting severe bleeding in patients with traumatic injuries in the neck. The device previously was approved for use on the leg, arm, scalp and groin. San Antonio Express-News (10/16)
Share: LinkedInTwitterFacebookGoogle+Email
FDA clears cervical fusion device from Precision Spine
The FDA has cleared Precision Spine to market its Vault-C Anterior Cervical Interbody Fusion Device, which the company said is now available commercially. The device comes with a zero profile design to provide stable screw fixation while keeping surrounding soft tissue and vessels unharmed. FDAnews (10/16)
Share: LinkedInTwitterFacebookGoogle+Email
AdvaMed News
Premarket Approval (PMA) Submissions Workshop
Thursday, Oct. 23 – Friday, Oct. 24
Washington Marriott at Metro Center
Completing the MTLI set of interactive submissions workshops, senior industry experts and members of the CDRH device evaluation and bioresearch monitoring staffs will lead participants through the strategic considerations and practical steps of filing a PMA, illustrated with real-world case studies. Topics include strategy development and evidence requirements, productive meetings with the FDA, the mechanics of submission development, advisory panels, inspectional activity, conditions of approval studies, and the care and feeding of approved PMAs. Visit MTLI online for more information.
Share: LinkedInTwitterFacebookGoogle+Email
Join the AdvaMed-MTLI LinkedIn group or follow them on Twitter!
Build close relationships with member companies, both small and large, and receive an intimate understanding of the key issues affecting innovation, access and the bottom line. Interact in discussions that leverage the leadership and expertise of the medical technology industry. This social group is full of key stakeholders, influencers and industry thought leaders as well as regulatory and policy experts from the FDA and CMS. Aside from practical learning opportunities, this LinkedIn group provides the premier opportunity to network with key players from virtually every aspect of the industry. Link to the AdvaMed MTLI LinkedIn group page.  Link to the AdvaMed MTLI Twitter account.
Share: LinkedInTwitterFacebookGoogle+Email
Who's Hiring?
Position TitleCompany NameLocation
PRIN CLIN RES SCNT - 140000050TAbbottSanta Clara, CA
Market Intelligence ManagerOlympus Corporation of the AmericasSouthborough, MA
Director, Quality Regulatory AffairsCardinal HealthChicago, IL
Click here to view more job listings.
People are like stained-glass windows. They sparkle and shine when the sun is out, but when the darkness sets in, their true beauty is revealed only if there is a light from within."
-- Elisabeth Kubler-Ross,
American psychiatrist
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Lisa Gough
Advertising:  Meryl Harold
  P: 202.407.7828
Jobs Contact:  Elizabeth Stack

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information